US Stock MarketDetailed Quotes

NBIX Neurocrine Biosciences

Watchlist
  • 120.270
  • +1.490+1.25%
Close May 15 16:00 ET
  • 122.000
  • +1.730+1.44%
Pre 04:05 ET
11.90BMarket Cap40.77P/E (TTM)

About Neurocrine Biosciences Company

Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research and development, commercialization, and sale of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. Its portfolio of products includes treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia (CAH), and endometriosis and uterine fibroids. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.

Company Profile

SymbolNBIX
Company NameNeurocrine Biosciences
Listing DateMay 23, 1996
Issue Price10.50
Founded1992
CEODr. Kyle W. Gano, PhD
MarketNASDAQ
Employees1800
Fiscal Year Ends12-31
Address6027 Edgewood Bend Court
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92130
Phone1-858-617-7600
Websitehttp://www.neurocrine.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Kyle W. Gano, PhD
  • Director, President and Chief Executive Officer
  • 8.54M
  • Dr. Eiry W. Roberts, M.D.
  • Chief Medical Officer
  • 6.76M
  • Julie S. Cooke
  • Chief Human Resources Officer
  • --
  • Matthew C. Abernethy
  • Chief Financial Officer and Principal Accounting Officer
  • 6.60M
  • Eric S. Benevich
  • Chief Commercial Officer
  • 6.31M
  • David W. Boyer
  • Chief Corporate Affairs Officer
  • --
  • Darin M. Lippoldt
  • Chief Legal Officer and Corporate Secretary
  • --
  • Dr. Jude Onyia, PhD
  • Chief Scientific Officer
  • 7.04M
  • Dr. Ingrid Delaet, PhD
  • Chief Regulatory Officer
  • --
  • Dr. William H. Rastetter,PhD
  • Chairman of the Board
  • 501.28K
  • Dr. Kevin C. Gorman,PhD
  • Director
  • 16.02M
  • Shalini Sharp
  • Independent Director
  • 499.09K
  • Leslie V. Norwalk, Esq.
  • Independent Director
  • 478.09K
  • Johanna Mercier
  • Independent Director
  • 469.09K
  • Christine A. Poon
  • Independent Director
  • 481.63K
  • Richard F. Pops
  • Independent Director
  • 489.09K
  • George J. Morrow
  • Independent Director
  • 481.03K
  • Gary A. Lyons
  • Independent Director
  • 470.09K
  • Dr. Stephen A. Sherwin, M.D.
  • Independent Director
  • 494.17K

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
Sample Name
Sample Code
 32.160
Sample Name
Sample Code
 48.950
Sample Name
Sample Code
 70.600
4
Constellation Brands
STZ
190.650
5
Workday
WDAY
274.710
Unlock Now

Discussing

Warren Buffett's Q1 Holdings Revealed: Has the Investment Trend Changed Drastically?
$Berkshire Hathaway-A (BRK.A.US)$ The first quarter Hold Positions report has been released, and the latest investment actions of the 'stock Show More
10 Unmissable Highlights of Berkshire's Shareholders Meeting

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 64.260
Sample Name
Sample Code
 1177.980
Sample Name
Sample Code
 404.690
4
Microsoft
MSFT
453.130
5
Broadcom
AVGO
232.640
Unlock Now
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 3.200
Sample Name
Sample Code
 0.6272
Sample Name
Sample Code
 8.480
4
The9 Ltd
NCTY
12.150
5
Ebang International
EBON
4.142
Unlock Now

Monetary Policy: Navigating the Fed's Rate Cut Cycle

Changing Fed policy is altering the market math for investors.

Earnings Season Underway

Earnings season is here. What to know?

- No more -